Vorapaxar for reducing atherothrombotic events after a myocardial infarction or in peripheral vascular disease [ID616]

  • Discontinued
  • GID-TAG493

Documents

Documents created during the development process.

Provisional matrix (pre-referral) - November 2013

Draft scope for consultation (pre-referral) - November 2013